Literal source text
Lobbying issues and bill citations
HCR · Health Issues
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
Literal federal measure citations: S. 1302, H.R. 1843, S. 775, HR1503, S. 2916, S. 2129, H.R. 5461, S. 891
CPT · Copyright/Patent/Trademark
IP Issues related to generic medicines Patent Settlements S 2220, The PREVAIL Act
Literal federal measure citations: S 2220
TRD · Trade (domestic/foreign)
Trade issues related to generic medicines Pharmaceutical supply chain
FIN · Financial Institutions/Investments/Securities
Policy related to corporate governance
DEF · Defense
S4638 2025 National Defense Authorization Act
Literal federal measure citations: S4638
BUD · Budget/Appropriations
HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
Literal federal measure citations: HR 9747
